MedPath

Effect of 24 h Severe Energy Restriction on Appetite Regulation and Ad-libitum Energy Intake

Not Applicable
Completed
Conditions
Deficiency; Calorie
Interventions
Other: Energy intake
Registration Number
NCT02696772
Lead Sponsor
Loughborough University
Brief Summary

Long term maintenance of weight loss is generally poor, which is at least partly due to increased feelings of hunger associated with restricting what can be eaten. Intermittent severe energy restriction is a novel dietary strategy that requires individuals to consume a very-low energy diet for 1-4 days per week, allowing normal feeding patterns to be adopted on the other days in the week. However, the effect of a consuming a very-low energy diet on appetite regulation, which might represent a key marker of long-term adherence to dieting, has not been determined. This study aimed to assess the effects of severely restricting energy intake for 24 h on markers of appetite regulation, energy balance and metabolism compared to an adequate energy trial.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
18
Inclusion Criteria
  • non-smoker, not currently dieting, weight stable for >6 months (self-reported), no known history of cardiovascular or renal disease.
Exclusion Criteria
  • food allergies, dislike or intolerance of study foods and drinks, irregular eating patterns, use of medication that could influence hormone concentrations, excessive alcohol consumption (>4 units/day), intensive training schedule (>10 h/week)

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Energy restrictionEnergy intakeIntervention day diet containing 25% of estimated energy requirements
Energy balanceEnergy intakeIntervention day diet containing 100% of estimated energy requirements
Primary Outcome Measures
NameTimeMethod
Ad-libitum energy intake48 hours

Measured at laboratory-based meals and weight food records

Plasma acylated Ghrelin24 hours

Measured using ELISA from venous blood samples

Plasma active glugagon-like peptide 124 hours

Measured using ELISA from venous blood samples

Subjective appetite48 hours

Measured using visual analogue scales

Secondary Outcome Measures
NameTimeMethod
Plasma glucose24 hours

Measured using colorimetric assay from venous blood samples

Fat oxidation24 hours

Measured under resting conditions using indirect calorimetry

carbohydrate oxidation24 hors

Measured under resting conditions using indirect calorimetry

Plasma Non-esterified Fatty acids24 hours

Measured using colorimetric from venous blood samples

Plasma insulin24 hours

Measured using ELISA from venous blood samples

Energy expenditure24 hours

Measured under resting conditions using indirect calorimetry

© Copyright 2025. All Rights Reserved by MedPath